G
GE Healthcare
Research & Biopharmaceutical Manufacturing - GE Healthcare Life Sciences
About GE Healthcare
GE Healthcare Systems is a leading provider of advanced technologies and digital infrastructure designed to enhance the diagnosis, treatment, and monitoring of patients. Operating primarily in the healthcare sector, the company serves a diverse range of clients including hospitals, clinics, and medical research institutions. GE Healthcare's product portfolio includes imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT solutions. The company leverages artificial intelligence (AI) and data analytics to improve clinical outcomes and operational efficiency. Its business model revolves around the sale of medical devices, software solutions, and related services, generating revenue through both direct sales and long-term service contracts. GE Healthcare invests heavily in research and development, with an annual R&D budget of $1 billion, ensuring continuous innovation and improvement of its offerings. The company supports over 300,000 patients daily using its imaging agents and manages 2 billion patient scans annually with its technology.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1892
- Headquarters
- Chicago, United States
- Listing
- IPO 2022
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 25.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Horizon Europe, observatoire healthtech, observatoire ia
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Computer Vision
- Investment activity
- 51 companies, latest Oct 2026
- Capital deployed
- $1.2B
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Dec 2025 | $1.3B | — | Undisclosed | ↗ |
| POST IPO DEBT✓Debt | Jun 2025 | $1.5B | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for GE Healthcare is 850K monthly website visits, up 6.3% over the last three months. GE Healthcare's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
SOFIEDulles Town Center, United StatesMolecular imaging company focused on empowering people with new pet technologies
$945Mvaluation
Intelerad Medical SystemsRaleigh, United StatesMaking a difference in global healthcare
$2.3Bvaluation
IcometrixLeuven, BelgiumAI-powered software for quantitative brain scan analysis
$98Mvaluation
MediviewCleveland, United StatesSurgical navigation system leveraging augmented reality and spatial computing to provide surgeons with advanced visualization
$96Mvaluation
EnliticLoveland, United StatesA modern machine learning company dedicated to revolutionizing diagnostic healthcare
$100Mvaluation
Nihon Medi-PhysicsTokyo, JapanNihon Medi-Physics Co is operates in the diagnostic nuclear medicine industry
$577Mvaluation
Exact TherapeuticsOslo, NorwayDeveloping a technology platform for targeted therapeutic enhancement
$4.9Mvaluation
Nucleus RadioPharmaRochester, United StatesTransforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise
$224Mvaluation
MIM SoftwareCleveland, United StatesPractical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging.
$259Mvaluation
Laza MedicalCampbell, United StatesImaging Solution for Cardiovascular Interventions
$144Mvaluation
Caption HealthBrisbane, United StatesMedical artificial intelligence (AI) company
$150Mvaluation
ImactisSaint-Martin-d'Hères, FranceGuides the radiologist's action to directly achieve a goal
$13Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Bill & Melinda Gates Foundation
Series B and later2 investors entered at this stage
General Electric
Vestor Capital
Other known investors2 additional known investors
Kortschak Investments
US Biomedical Advanced Research and Development Authority
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about GE Healthcare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GE Healthcare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.